Alexion全球患者倡导负责人Lenja Wiehe在#BIOPACE26主持讨论,探讨临床指南如何帮助患者突破保险障碍、在临床中获得所需治疗。参与嘉宾包括美国重症肌无力协会执行主任Allison Foss、NCCN患者信息运营助理副总裁Dottie Shead,以及Rare Advocates政策与倡导高级副总裁Jamie Sullivan。
Insurance barriers can stand between patients and the care they need, and clinical guidelines can help break them down. Lenja Wiehe, Director, Global Patient Advocacy Lead at @AlexionPharmaUS, moderated a #BIOPACE26 conversation on how guidelines can help patients get access in the clinic.
She was joined by Allison Foss, Executive Director of Myasthenia Gravis Association; Dottie Shead, Assistant Vice President, Patient Information Operations at @NCCN; and Jamie Sullivan, Senior Vice President of Policy and Advocacy at @RareAdvocates.
来源:Biotechnology Innovation Organization · x.com